Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Biogen Idec Forms First-of-Its-Kind Research Consortium to Identify ALS Drug Targets
Biogen Idec Forms First-of-Its-Kind Research Consortium to Identify ALS Drug Targets
Biogen Idec Forms First-of-Its-Kind Research Consortium to Identify ALS Drug Targets
Submitted by
admin
on December 20, 2012 - 11:15am
Source:
Yahoo
News Tags:
Biogen Idec
ALS
amyotrophic lateral sclerosis
Headline:
Biogen Idec Forms First-of-Its-Kind Research Consortium to Identify ALS Drug Targets
Do Not Allow Advertisers to Use My Personal information
